{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T18:27:00Z","timestamp":1777573620100,"version":"3.51.4"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100019000","name":"Ministry of National Defense Medical Affairs Bureau","doi-asserted-by":"publisher","award":["MND-MAB-D-112140"],"award-info":[{"award-number":["MND-MAB-D-112140"]}],"id":[{"id":"10.13039\/501100019000","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010425","name":"Tri-Service General Hospital","doi-asserted-by":"publisher","award":["TSGH-D-112078"],"award-info":[{"award-number":["TSGH-D-112078"]}],"id":[{"id":"10.13039\/501100010425","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010425","name":"Tri-Service General Hospital","doi-asserted-by":"publisher","award":["TSGH-E-113230"],"award-info":[{"award-number":["TSGH-E-113230"]}],"id":[{"id":"10.13039\/501100010425","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.ejphar.2024.177235","type":"journal-article","created":{"date-parts":[[2024,12,24]],"date-time":"2024-12-24T11:39:04Z","timestamp":1735040344000},"page":"177235","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Pyr3 inhibits cell viability and PKC\u03b1 activity to suppress migration in human bladder cancer cells"],"prefix":"10.1016","volume":"988","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5529-0330","authenticated-orcid":false,"given":"Hui-Kung","family":"Ting","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Chien","family":"Dou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-6776-874X","authenticated-orcid":false,"given":"Yi-Hsuan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tzu-Min","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Ling","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-Chiuan","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheng-Tang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6303-5858","authenticated-orcid":false,"given":"Ying","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2024.177235_bib1","doi-asserted-by":"crossref","first-page":"5179","DOI":"10.1523\/JNEUROSCI.5499-06.2007","article-title":"TRPC3 channels are necessary for brain-derived neurotrophic factor to activate a nonselective cationic current and to induce dendritic spine formation","volume":"27","author":"Amaral","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2024.177235_bib2","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21051739","article-title":"Transient receptor potential canonical (TRPC) channels as modulators of migration and invasion","volume":"21","author":"Asghar","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2024.177235_bib3","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1159\/000492293","article-title":"Pyr3 induces apoptosis and inhibits migration in human glioblastoma cells","volume":"48","author":"Chang","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.ejphar.2024.177235_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/cells9091983","article-title":"Transient receptor potential canonical (TRPC) channels: then and now","volume":"9","author":"Chen","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.ejphar.2024.177235_bib5","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s41389-021-00329-8","article-title":"Dysregulated G2 phase checkpoint recovery pathway reduces DNA repair efficiency and increases chromosomal instability in a wide range of tumours","volume":"10","author":"Fernando","year":"2021","journal-title":"Oncogenesis"},{"key":"10.1016\/j.ejphar.2024.177235_bib6","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1007\/s13402-022-00710-8","article-title":"Inhibition of PP2A by LB100 sensitizes bladder cancer cells to chemotherapy by inducing p21 degradation","volume":"45","author":"Gao","year":"2022","journal-title":"Cell. Oncol."},{"key":"10.1016\/j.ejphar.2024.177235_bib7","doi-asserted-by":"crossref","first-page":"e77","DOI":"10.1038\/oncsis.2013.40","article-title":"The histone variant MacroH2A regulates Ca(2+) influx through TRPC3 and TRPC6 channels","volume":"2","author":"Kim","year":"2013","journal-title":"Oncogenesis"},{"key":"10.1016\/j.ejphar.2024.177235_bib8","doi-asserted-by":"crossref","first-page":"5400","DOI":"10.1073\/pnas.0808793106","article-title":"Selective and direct inhibition of TRPC3 channels underlies biological activities of a pyrazole compound","volume":"106","author":"Kiyonaka","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ejphar.2024.177235_bib9","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/j.urology.2005.01.007","article-title":"Role of protein kinase C-alpha in superficial bladder carcinoma recurrence","volume":"65","author":"Kong","year":"2005","journal-title":"Urology"},{"key":"10.1016\/j.ejphar.2024.177235_bib10","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.canlet.2021.07.038","article-title":"TRPC3 promotes tumorigenesis of gastric cancer via the CNB2\/GSK3beta\/NFATc2 signaling pathway","volume":"519","author":"Lin","year":"2021","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ejphar.2024.177235_bib11","doi-asserted-by":"crossref","first-page":"418","DOI":"10.7150\/ijbs.23602","article-title":"Glaucocalyxin A induces G2\/M cell cycle arrest and apoptosis through the PI3K\/Akt pathway in human bladder cancer cells","volume":"14","author":"Lin","year":"2018","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.ejphar.2024.177235_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2024.103951","article-title":"Small molecules targeting canonical transient receptor potential channels: an update","volume":"29","author":"Liu","year":"2024","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejphar.2024.177235_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.coph.2016.03.002","article-title":"Alterations of calcium homeostasis in cancer cells","volume":"29","author":"Marchi","year":"2016","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.ejphar.2024.177235_bib14","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1161\/STROKEAHA.113.679332","article-title":"Transient receptor potential canonical 3 inhibitor Pyr3 improves outcomes and attenuates astrogliosis after intracerebral hemorrhage in mice","volume":"44","author":"Munakata","year":"2013","journal-title":"Stroke"},{"key":"10.1016\/j.ejphar.2024.177235_bib15","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1111\/j.1476-5381.2012.02126.x","article-title":"Novel pyrazole compounds for pharmacological discrimination between receptor-operated and store-operated Ca(2+) entry pathways","volume":"167","author":"Schleifer","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2024.177235_bib16","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ejphar.2024.177235_bib17","article-title":"TRPC3 regulates the proliferation and apoptosis resistance of triple negative breast cancer cells through the TRPC3\/RASA4\/MAPK pathway","volume":"11","author":"Wang","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.ejphar.2024.177235_bib18","doi-asserted-by":"crossref","first-page":"4047","DOI":"10.1007\/s00345-020-03569-2","article-title":"Follow-up in non-muscle invasive bladder cancer: facts and future","volume":"39","author":"Witjes","year":"2021","journal-title":"World J. Urol."},{"key":"10.1016\/j.ejphar.2024.177235_bib19","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.omtn.2020.06.010","article-title":"lncRNA SNHG1 promotes basal bladder cancer invasion via interaction with PP2A catalytic subunit and induction of autophagy","volume":"21","author":"Xu","year":"2020","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.ejphar.2024.177235_bib20","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1038\/onc.2008.475","article-title":"Transient receptor potential channel C3 contributes to the progression of human ovarian cancer","volume":"28","author":"Yang","year":"2009","journal-title":"Oncogene"},{"key":"10.1016\/j.ejphar.2024.177235_bib21","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1021\/acsmedchemlett.0c00571","article-title":"Discovery of a highly selective and potent TRPC3 inhibitor with high metabolic stability and low toxicity","volume":"12","author":"Zhang","year":"2021","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejphar.2024.177235_bib22","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1186\/s12885-017-3401-7","article-title":"Protein kinase C-alpha (PKCalpha) modulates cell apoptosis by stimulating nuclear translocation of NF-kappa-B p65 in urothelial cell carcinoma of the bladder","volume":"17","author":"Zheng","year":"2017","journal-title":"BMC Cancer"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299924009257?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299924009257?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T19:20:12Z","timestamp":1777404012000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299924009257"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":22,"alternative-id":["S0014299924009257"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2024.177235","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pyr3 inhibits cell viability and PKC\u03b1 activity to suppress migration in human bladder cancer cells","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2024.177235","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"177235"}}